Safety Shot announced on August 11 the creation of a corporate BONK treasury, receiving $25 million in tokens through a strategic alliance with BONK founding contributors.
The Nasdaq-listed company issued $35 million in convertible preferred shares as consideration for the allocation.
The arrangement positions Safety Shot among a growing cohort of public companies adopting altcoin treasury strategies beyond traditional Bitcoin holdings.
Recent corporate altcoin moves include Bit Origin arranging $500 million for Dogecoin (DOGE) accumulation and SharpLink Gaming disclosing nearly 600,000 ETH holdings.
Safety Shot CEO Jarrett Boon stated:
“This strategic partnership represents the first stage of a much broader corporate evolution for our company. By aligning with one of the most exciting ecosystems in digital assets, we are taking a bold first step.”
The partnership includes plans for expanded collaboration across the Solana ecosystem as Safety Shot develops its digital asset infrastructure.
Technical infrastructure drives selection
Safety Shot cited BONK’s Solana blockchain foundation as a key factor in the treasury decision.
The company noted BONK’s high-speed, low-cost transaction capabilities provide advantages over Ethereum-based competitors like Shiba Inu and Pepe, which they claimed face network congestion and elevated fees.
BONK held a market capitalization exceeding $2 billion as of press time, making it the fifth-largest memecoin.
The allocation follows Safety Shot’s debt settlement and balance sheet optimization, which left the company with over $15 million in cash reserves. The BONK tokens will serve as core treasury assets within Safety Shot’s broader digital asset strategy.
Broader altcoin treasury adoption
Corporate cryptocurrency treasury adoption has accelerated throughout 2025, with companies diversifying beyond Bitcoin (BTC) into specialized blockchain ecosystems.
XRP corporate treasury commitments are also increased through companies like Trident Digital, Webus International, and VivoPower International, demonstrating institutional appetite for BTC alternatives.
Windtree Therapeutics secured agreements for up to $200 million to establish BNB reserves, while Sonnet BioTherapeutics earmarked $583 million in HYPE tokens for balance-sheet deployment.
Mentioned in this article
